Bank of America Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)

Bank of America assumed coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a report released on Monday morning, Marketbeat reports. The firm issued a buy rating and a $30.00 price objective on the stock.

Several other research firms have also recently issued reports on KMTS. Wolfe Research started coverage on shares of Kestra Medical Technologies in a research report on Monday. They set an “outperform” rating and a $29.00 price objective on the stock. The Goldman Sachs Group began coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “neutral” rating and a $24.00 price target on the stock. Piper Sandler began coverage on Kestra Medical Technologies in a research report on Monday. They set an “overweight” rating and a $27.00 price objective for the company. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $28.00 target price on the stock. Finally, Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a report on Monday. They set a “buy” rating and a $28.00 price target for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $27.67.

Kestra Medical Technologies Stock Performance

Shares of KMTS opened at $24.92 on Monday. Kestra Medical Technologies has a 12-month low of $20.00 and a 12-month high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.